Dr Janice Chew-Harris received her PhD degree from University of Otago in Christchurch, New Zealand at the end of 2016. Her research is focused on measurements and detection of novel plasma and urinary biomarkers. Her current research aims to assess the performances of biomarkers and their prognostic abilities in predicting risk, earlier detection and in guiding therapy, in both acute and progressive forms of cardiac and renal diseases. She is also interested in studies relating to mechanisms and modulation of cardiorenal syndromes. She has previously worked as a medical laboratory scientist (Clinical Biochemistry) and is trained in many advanced laboratory methods.
